RegMed: Regenerative Medicine Innovation Platform
The province of Flemish Brabant (Belgium) and its neighbouring regions together have a leading role in regenerative and personalised medicine research, translation, industrialisation, dissemination and clinical implementation. Also a critical mass of experienced and complementary actors along the complete value chain is present in this region. To maintain and strengthen this unique and high potential position in regenerative medicine a customised strategic innovation platform was established.
The goal of this Regenerative Medicine Innovation Platform (RegMed) is to create a leading public-private community that, by building on its regional actors, can drive regenerative medicine towards a real industry with clinical applications and a socio-economical return.
Look for more information about the platform, the cross-border cooperations, the technolgy schowcases ... Click on the pictures on the right side.
Please contact for more information: Jan Schrooten, Antleron, jan.schrooten@antleron.com, tel +32 (0) 494 91 47 74
RegMed: Innovatieplatform voor Regeneratieve Geneeskunde
Aan de top
Vlaams-Brabant staat aan de top in Europa op het onderzoeksgebied van ‘regeneratieve geneeskunde’. Dat is een nieuwe tak van de geneeskunde waarbij artsen je weer gezond maken door bijvoorbeeld een nieuwe nier, huid of kraakbeen te bouwen uit gekweekte cellen en biomaterialen. Neen, dit is geen sciencefiction: wetenschappers, ingenieurs en artsen verwachten een aantal van die oplossingen al over enkele jaren toe te passen. Ze combineren daarvoor technieken zoals het kweken van biologisch en synthetisch materiaal in een bioreactor, met 3D-printing, waarbij je eender welk materiaal laag na laag op elkaar aanbrengt of print.
Stap voor stap
Deze nieuwe mogelijkheden zullen stap voor stap doorbreken.
Samen sterk
Geen enkele universiteit, kliniek of bedrijf heeft alle kennis en kunde in huis om de noodzakelijke volgende stappen op eigen houtje te zetten. Met steun van de provincie hebben alle betrokken regionale spelers daarom een Innovatieplatform voor Regeneratieve Geneeskunde opgezet. Bedoeling van het platform is om met de meer dan twintig partners in overleg het pad uit te tekenen en gezamenlijk tot actie over te gaan. Op die manier blijft onze regio een voortrekker in dit innovatieve domein. Het platform zoekt ook internationale samenwerkingen met andere regio’s die inzetten op regeneratieve geneeskunde, zoals met Nederlands-Limburg.
Niet-genezende breuken.
Kijk voor meer info over het platform, de internationale samenwerking, de technologische onderzoekssamenwerkingen... Klik op de figuren in de rechterbalk
Meer info: Jan Schrooten, Antleron, jan.schrooten@antleron.com, tel +32 (0) 494 91 47 74
AML Clinical Services provides focused clinical research services to pharmaceutical, medical device and biotechnology companies, CROs and research sites.
We can advise and support members of the Reg Med platform in the start-up and monitoring of their clinical trials. We also provide training in the regulatory aspects of clinical trials.
Contact: Anne-Mie Lenaers
Antleron, an engineering start-up, aims to accelerate the development of next generation advanced therapies and medical devices by merging the potential of cells, biomaterials, biologics, 3D printing and bioreactors. Being part of the RegMed community is essential for Antleron’s business philosophy as it wants to run a project-based collaborative development model at the interface between life science and manufacturing industry to deliver socio-economically viable regenerative products that address unmet clinical needs.
Contact: jan.schrooten@antleron.com
CMAST is actief binnen RegMed en beschikt over een team van meer dan 90 experts. Samen ondersteunen ze bedrijven en kennis- en onderzoeksinstellingen binnen de gezondheidssector. CMAST biedt advies, projectmanagement en realistische oplossingen voor bedrijven.
Contact: avanechelpoel@cmast.be
De Clercq & Partners is helping companies optimize the protection of their intellectual property in the field of regenerative medicine. Added value for the platform: Keeping track of legal developments in this field and informing the platform, identifying potential IP issues for initiatives of the platform.
GLOBAL STEM CELL TECHNOLOGY (GST) is a privately-owned company that is part of the Evergem based Health Care provider, ANACURA. GST focusses on the isolation and characterization of blood-derived mesenchymal stem cells and skin-derived epithelial stem cells. GST developed different organ culture systems and experimental animal models to properly assess these cells in vitro and in vivo.
Contact: jan.spaas@anacura.com
3D Systems LayerWise makes its in-house developed metal 3D printing technology available for the manufacturing of complex metal parts and implants. These implants can feature complex designs and porous architectures that are optimized to achieve the desired tissue response in a regenerative medicine application and thus create ‘smart’ implants. Through the 3D Systems network, LayerWise also has access to 3D printing of biocompatible polymers.
Contact: Tim.VanCleynenbreugel@3DSystems.com
MaSTherCell is a dynamic and global Contract Development and Manufacturing Organization (CDMO) on a mission to deliver optimized process industrialization capacities to cell therapy organizations, and speed up the arrival of their therapies onto the market. The company operates a validated state-of-the-art cGMP facility in Gosselies.
Medanex Clinic is a CRO specialized in in preclinical in-vivo research using large animals (rabbit, sheep, goat, (mini)pig, cattle, llama and horse). Our main activities are pre-clinical studies and surgery trainings for academic research groups, medical device, pharmaceutical and biotech companies. Our in-house equipment consists of state-of-the-art operating theatres, intensive care units, anesthetic equipment, fluoroscopy, ultrasonography and X-ray. We also provide MRI, CT and (histo)pathology services through experienced partners. Medanex’ core values are animal welfare, quality, flexibility and competence.
Contact: hadewych.vanhauwermeiren@medanex.com
The division M3-BIORES of the Department of Biosystems focuses on the development of model-based methods for monitoring and controlling of complex biological processes at different scales. M3-BIORES is partner of Prometheus and within the field of regenerative medicine the division aims at developing real-time process monitoring and controlling tools for optimizing in vitro cell cultures.
Contact: jean-marie.aerts@biw.kuleuven
Imec is a non-profit research organization in nanotechnology. At imec we aim to develop technology blocks for life sciences applications. As a member of the Regenerative Medicine innovation platform imec hopes to receive input from companies and research labs on the technology needs for novel bioreactors. We offer development on demand with input from stem cell researchers. Imec has a bilateral collaboration with Prometheus (KULeuven) to develop technology for controlled cell growth, focusing on lens-free imaging and biosensing.
Contact: Veerle.Reumers@imec.be or Peter.Peumans@imec.be
Prometheus is a translational platform in the field of regenerative medicine. To achieve this, it integrates and advances the scientific and technological knowledge of its partners. This unique transdisciplinary team organizes its activities on the scientific, industrial-technical and preclinical level to develop robust and clinically relevant tissue engineering approaches for skeletal applications.
Our mission is to be a communication and facilitating platform, bringing together students, researchers, young starters, high-tech entrepreneurs, spin-offs and established enterprises and socio-economic partners. We do this through the coordination of events and activities, such as the (international) visionary seminars where an insight is given in the expected trends of the near future. In addition we organise numerous seminars on a specific technology or management theme, based on the present-day evolutions of the international technology market.
The Leuven.Inc network covers areas of expertise ranging from micro and nano electronics, engineering, health and medical research to ICT, life sciences, food, materials and many more.
Contact: nicole.desmyter@leuveninc.com
De provincie Vlaams-Brabant zet in op verantwoord ondernemerschap, innovatie en de uitbouw van de kennisregio. Voor de opbouw van een gezond economisch weefsel, duurzame tewerkstelling in de regio en het behoud en de groei van de welvaart in Vlaams-Brabant.
Kijk voor subsidies: http://www.vlaamsbrabant.be/info/subsidies/index.jsp#paragraph1
Up till now more than 40 members have joined the multidisciplinary platform. Regional governments, university labs, pharmaceutical companies (spin offs, SME or larger), hospitals, 3D-printing specialists, all sort of suppliers... venture capitalists and legal advisors are active participants. Crossborder cooperation with Nederlands Limburg has been established and the closing of the regional value chain is advancing.
Please contact: Jan Schrooten, jan.schrooten@antleron.com, tel +32 (0) 494 91 47 74
Our new memberpage is lacking lots of information . Please give us your company name, logo, url, short company role in regenerative medicine and added value to the platform, relevant images and contact info
De provincie Vlaams-Brabant en Leuven MindGate organiseren vanaf 29 maart in Leuven, Gent en Hasselt 8 interactieve sessies waarbij ondernemers van 20 jonge MedTech en BioTech-bedrijven leren internationaliseren.
De provincie Vlaams-Brabant liet onderzoeken welke knelpunten bedrijven in de health cluster ervaren om te groeien en welke internationale bedrijven er nog ontbreken in de waardeketen.
